Cumberland Pharmaceuticals Inc. CPIX
Set alert
4.69 USD +0.34 +7.82%
At close · Oct 30
4.61 -0.08 -1.70%
After hours · Oct 30, 5:49 PM ET
4.35 Day range 4.76
1.90 52-week range 8.97
- YTD
- +17.84%
- 1 year
- +46.11%
- Open
- 4.35
- Prev close
- 4.35
- Mkt cap
- 70.27M
- Vol
- 128.96K
- Avg vol
- 84.11K
- EPS
- -0.62
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.35
- High
- 4.76
- Forward P/E
- 16.07
- Beta
- 0.22
- Short ratio
- 0.92
- Inst. own
- 14.69%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.40
- 200-d avg
- 1.48
- 1y target
- 0.00
Financial health
Altman Z-Score
0.13 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 1
Valuation
P/E -20.9×
FY 2016 5y median -5.9× FY 2025
P/S 1.3×
FY 2016 5y median 0.9× FY 2025
P/B 2.4×
FY 2016 5y median 1.5× FY 2025
P/FCF 12.3×
FY 2016 5y median 5.1× FY 2025
EV/EBITDA 19.7×
FY 2016 5y median 102× FY 2025
EV/Sales 1.3×
FY 2016 5y median 0.9× FY 2025
FCF Yield 8.1%
FY 2016 5y median 8.6% FY 2025
Profitability
Gross Margin 85.0%
FY 2016 5y median 82.6% FY 2025
Operating Margin -6.3%
FY 2016 5y median -17.0% FY 2025
Net Margin -6.4%
FY 2016 5y median -13.3% FY 2025
ROE -11.4%
FY 2016 5y median -15.4% FY 2025
ROIC -6.9%
FY 2016 5y median -11.6% FY 2025
ROA -3.7%
FY 2016 5y median -6.0% FY 2025
Growth (YoY)
Revenue 17.6%
FY 2016 FY 2025
Operating Income 56.6%
FY 2016 FY 2025
EPS (diluted) 58.7%
FY 2016 FY 2025
Free Cash Flow 710.5%
FY 2016 FY 2025
Financial Health
Current Ratio 1.0×
FY 2016 5y median 1.3× FY 2025
Quick Ratio 0.8×
FY 2016 5y median 1.1× FY 2025
Debt / Equity 0.4×
FY 2016 5y median 0.6× FY 2025
Net Debt / EBITDA -0.4×
FY 2016 5y median 3.6× FY 2025
Interest Coverage -5.6×
FY 2016 5y median -10.6× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31